Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis.

Next Previous
Trial Profile

Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis.

Status: Discontinued
Phase of Trial: Phase I

Latest Information Update: 22 Dec 2011

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Thalidomide (Primary)
  • Indications Pelvic pain
  • Focus Therapeutic Use

Most Recent Events

  • 19 Dec 2011 Planned end date changed from 1 Nov 2010 to 1 Aug 2009 as reported by ClinicalTrials.gov.
  • 19 Dec 2011 Actual patient number (9) added as reported by ClinicalTrials.gov.
  • 05 Jan 2011 Planned end date changed from 1 Feb 2010 to 1 Nov 2010 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top